Cardiology

The study reports that risk is greater in female patients and those born small for gestational age. However, overall causality is still uncertain.

Our latest emergency department minute quiz from Brady Pregerson, MD, features a patient in his 20s with a history of pancreatitis presenting with epigastric and chest pain.

In this column, titled "Give Them Back Their Clothes", Dr. Paul Thompson reflects on the importance of creating a personal connection with patients as part of their care routine and the impact it can have on patients.

A retrospective analysis of more than 7k patients from the ACCORD trial suggests intensive blood pressure and intensive blood glucose control could reduce the risk of cardiovascular autonomic neuropathy in diabetics.

Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.

Novartis indicates they will address manufacturing issues cited by the FDA.

Patients with any presence of small vessel disease had a 2-times greater risk of recurrent ischemic stroke than those without.

Results of the INVESTED trial are shedding light on cardiovascular and pulmonary outcomes among patients with high-risk cardiovascular disease receiving standard-dose vs high-dose influenza vaccines.

Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.

There were similar rates of primary outcome events in the high-dose and standard-dose vaccination groups.

An analysis of more than 7k patients with CAN data from the ACCORD trial suggest intensive blood pressure and blood glucose control could reduce risk of cardiovascular autonomic neuropathy.

Learn more about the importance of educating patients on the differences between store-bought fish oil supplements and therapies derived from omega-3 such as icosapent ethyl (Vascepa).

Despite these findings, there is still uncertainty as to whether mitigating symptoms of depression can lower cardiovascular risk.

The agency is expected to rule on the Novartis treatment in 2021.

The FDA's Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 12 to 1 in favor of an indication for sacubitril/valsartan (Entresto) during a December 15 meeting.

Dr. Paul Thompson reflects on the diagnosis and treatment of hypertrophic cardiomyopathy and other comorbid conditions, in this column, titled "Don’t Be Thick Headed With Thick Hearts".

An analysis of more than 25 studies with more than 1 million patients is giving an overview of how the timing of a diabetes diagnosis can impact risk of complications later in life.

Results of CardioLink-9 suggest icosapent ethyl could provide symptom relief and reduce inflammation in patients with COVID-19.

An analysis of more than 7k patients from Brazil suggests high blood pressure at any age and for any amount of time was linked to accelerated cognitive decline later in life.

An analysis of 2 major studies is comparing the effects of bariatric surgery vs standard medical therapy on risk of cardiovascular disease events in obese teens with type 2 diabetes.

Dr. Gregory Weiss explores and gives perspective on the latest guidelines from the AHA and ACC outlining quality measures for adults with atrial fibrillation or atrial flutter

A resident from Penn State Hershey Medical Center offers perspective on the idea of using SGLT2 inhibitors for primary prevention in patients with type 2 diabetes.

A comparison of data from Teen-LABS and TODAY offer insight into the effects of medical therapy alone vs bariatric surgery in obese teens with type 2 diabetes.

There is concern over whether or not patients are adhering to their treatment during the pandemic.

An analysis of data from more than 900k Veterans suggests use of SSRIs in those with PTSD was associated with an increased risk of hemorrhagic stroke.

Dr. Gerald Shulman discusses how diabetes can eventually be reversed.

An analysis of data from Geisinger suggests living closer to fracking activity could increase a person's risk of hospitalization for heart failure.

By addressing insulin resistance, researchers believe they can reduce the comorbidities associated with type 2 diabetes.

Dr. Giorgino discusses how combining SGLT2 Inhibitors and GLP-1RA could be combined for treating type 2 diabetes.

A resident from Penn State Hershey Medical Center offers his perspective on the potential of the SGLT2 inhibitor class to transform the treatment of diabetes and cardiovascular disease among patients with diabetes.